Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah W Book

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Addictive Behaviors|June 5, 2012
Severity of anxiety in mental health versus addiction treatment settings when social anxiety and substance abuse are comorbidSarah W Book, Suzanne E Thomas, Joshua P Smith, et al.
Journal of Substance Abuse Treatment|January 21, 2015
Discontinuation of buprenorphine maintenance therapy: perspectives and outcomesBrandon S Bentzley, Kelly S Barth, Sudie E Back, et al.
Substance Abuse|April 12, 2012
Client attitudes toward alcohol use self-reportSarah W Book, Suzanne E Thomas, Scott H Stewart, et al.
Journal of Anxiety Disorders|April 24, 2007
Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorderSarah W Book, Suzanne E Thomas, Patrick K Randall, et al.
Journal of Substance Abuse Treatment|April 23, 2015
Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance TherapyBrandon S Bentzley, Kelly S Barth, Sudie E Back, et al.
Addictive Behaviors|February 7, 2009
Social anxiety impacts willingness to participate in addiction treatmentSarah W Book, Suzanne E Thomas, Jared P Dempsey, et al.
Journal of Addiction Medicine|June 3, 2024
Sleep as an Important Target or Modifier in Alcohol Use Disorder Clinical Treatment: Example From a Recent Gabapentin Randomized Clinical TrialMichaela Hoffman, Konstantin Voronin, Sarah W Book, et al.
Comprehensive Psychiatry|February 17, 2009
Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptomsJared P Dempsey, Patrick K Randall, Suzanne E Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2022
Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcaponeJoseph P Schacht, Yeongbin Im, Michaela Hoffman, et al.
Journal of Substance Use|July 2, 2014
The potential utility of drinking motive questions to screen at-risk drinking in socially anxious patientsPeter M Miller, Sarah W Book, Suzanne Thomas, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Addictive Behaviors|June 5, 2012
Severity of anxiety in mental health versus addiction treatment settings when social anxiety and substance abuse are comorbidSarah W Book, Suzanne E Thomas, Joshua P Smith, et al.
Journal of Substance Abuse Treatment|January 21, 2015
Discontinuation of buprenorphine maintenance therapy: perspectives and outcomesBrandon S Bentzley, Kelly S Barth, Sudie E Back, et al.
Substance Abuse|April 12, 2012
Client attitudes toward alcohol use self-reportSarah W Book, Suzanne E Thomas, Scott H Stewart, et al.
Journal of Anxiety Disorders|April 24, 2007
Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorderSarah W Book, Suzanne E Thomas, Patrick K Randall, et al.
Journal of Substance Abuse Treatment|April 23, 2015
Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance TherapyBrandon S Bentzley, Kelly S Barth, Sudie E Back, et al.
Addictive Behaviors|February 7, 2009
Social anxiety impacts willingness to participate in addiction treatmentSarah W Book, Suzanne E Thomas, Jared P Dempsey, et al.
Journal of Addiction Medicine|June 3, 2024
Sleep as an Important Target or Modifier in Alcohol Use Disorder Clinical Treatment: Example From a Recent Gabapentin Randomized Clinical TrialMichaela Hoffman, Konstantin Voronin, Sarah W Book, et al.
Comprehensive Psychiatry|February 17, 2009
Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptomsJared P Dempsey, Patrick K Randall, Suzanne E Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2022
Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcaponeJoseph P Schacht, Yeongbin Im, Michaela Hoffman, et al.
Journal of Substance Use|July 2, 2014
The potential utility of drinking motive questions to screen at-risk drinking in socially anxious patientsPeter M Miller, Sarah W Book, Suzanne Thomas, et al.
Pageof 4